Tocilizumab vs. anti-TNFα agents for resolution of uveitic macular edema
- Posted on: Jan 26 2022
- Leave a response
This retrospective study assessed the efficacy and safety of tocilizumab and anti–tumor necrosis factor alpha (TNFα) agent for the control of ocular inflammation in patients with noninfectious uveitis and macular edema (ME).
Source: AAO
Posted in: Uncategorized